Beirne Wealth Consulting Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,393
Closed -$230K 110
2021
Q3
$230K Hold
2,393
0.13% 93
2021
Q2
$297K Sell
2,393
-7
-0.3% -$835 0.16% 78
2021
Q1
$316K Sell
2,400
-1,682
-41% -$230K 0.19% 66
2020
Q4
$541K Buy
4,082
+17
+0.4% +$2.06K 0.27% 70
2020
Q3
$414K Buy
4,065
+1,665
+69% +$144K 0.24% 73
2020
Q2
$209K Buy
+2,400
New +$192K 0.17% 68
2020
Q1
Sell
-2,400
Closed -$222K 83
2019
Q4
$222K Hold
2,400
0.2% 80
2019
Q3
$217K Hold
2,400
0.18% 121
2019
Q2
$283K Sell
2,400
-641
-21% -$64.6K 0.25% 104
2019
Q1
$263K Buy
+3,041
New +$259K 0.21% 147

Other funds holding EXAS

Beirne Wealth Consulting Services's EXAS Position: Q4 2021 in Review

Beirne Wealth Consulting Services sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 2,393 shares — an estimated $230K sold.

Beirne Wealth Consulting Services first reported a position in EXAS in Q1 2019 and held it in 10 quarters. The position peaked at $541K in Q4 2020. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Beirne Wealth Consulting Services reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 2,393 Exact Sciences shares in Q4 2021, an estimated $230K.
  • Beirne Wealth Consulting Services first reported a position in Exact Sciences in Q1 2019 and held it in 10 quarters.
  • Beirne Wealth Consulting Services's Exact Sciences position peaked at $541K in Q4 2020.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Beirne Wealth Consulting Services's 13F filing for Q4 2021, filed 3 Feb 2022.